The quest for eldorado : Development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain : PET and SPECT in drug evaluation and drug design: Novel techniquesHORTI, Andrew G; VILLEMAGNE, Victor L.Current pharmaceutical design. 2006, Vol 12, Num 30, pp 3877-3900, issn 1381-6128, 24 p.Article

Molecular mechanisms for Alzheimer's disease : implications for neuroimaging and therapeuticsMASTERS, Colin L; CAPPAI, Roberto; BAMHAM, Kevin J et al.Journal of neurochemistry. 2006, Vol 97, Num 6, pp 1700-1725, issn 0022-3042, 26 p.Article

Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort studyPIETRZAK, Robert H; SCOTT, J. Cobb; MASTERS, Colin L et al.British journal of psychiatry (Print). 2014, Vol 204, Num 5, pp 400-401, issn 0007-1250, 2 p.Article

Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PETOKAMURA, Nobuyuki; FURUMOTO, Shozo; ROWE, Christopher C et al.Brain. 2014, Vol 137, pp 1762-1771, issn 0006-8950, 10 p., 6Article

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB―PET longitudinal studyVILLAIN, Nicolas; CHETELAT, Gaël; MASTERS, Colin L et al.Brain. 2012, Vol 135, pp 2126-2139, issn 0006-8950, 14 p., 7Article

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adultsYEN YING LIM; ELLIS, Kathryn A; SZOEKE, Cassandra et al.Neurology. 2012, Vol 79, Num 16, pp 1645-1652, issn 0028-3878, 8 p.Article

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)ELLIS, Kathryn A; SZOEKE, Cassandra; MCBRIDE, Simon J et al.International psychogeriatrics. 2014, Vol 26, Num 4, pp 543-554, issn 1041-6102, 12 p.Article

The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCIHARRINGTON, Karra D; YEN YING LIM; ROWE, Christopher et al.International psychogeriatrics. 2013, Vol 25, Num 10, pp 1667-1677, issn 1041-6102, 11 p.Article

Subtypes of progressive aphasia: application of the international consensus criteria and validation using β-amyloid imagingLEYTON, Cristian E; VILLEMAGNE, Victor L; SAVAGE, Sharon et al.Brain. 2011, Vol 134, pp 3030-3043, issn 0006-8950, 14 p., 10Article

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL studyPIKE, Kerryn E; ELLIS, Kathryn A; MASTERS, Colin L et al.Neuropsychologia. 2011, Vol 49, Num 9, pp 2384-2390, issn 0028-3932, 7 p.Article

MR atlas of the baboon brain for functional neuroimagingGREER, Phil J; VILLEMAGNE, Victor L; RUSZKIEWICZ, James et al.Brain research bulletin. 2002, Vol 58, Num 4, pp 429-438, issn 0361-9230, 10 p.Article

In vitro characterization of [¹⁸F]-florbetaben, an Aβ imaging radiotracerFODERO-TAVOLETTI, Michelle T; BROCKSCHNIEDER, Damian; MASTERS, Colin L et al.Nuclear medicine and biology. 2012, Vol 39, Num 7, pp 1042-1048, issn 0969-8051, 7 p.Article

Relationship between Atrophy and β-Amyloid Deposition in Alzheimer DiseaseCHETELAT, Gaël; VILLEMAGNE, Victor L; SALVADO, Olivier et al.Annals of neurology. 2010, Vol 67, Num 3, pp 317-324, issn 0364-5134, 8 p.Article

Cerebral β-Amyloid Detected by Pittsburgh Compound B Positron Emission Topography Predisposes to Recombinant Tissue Plasminogen Activator-Related HemorrhageLY, John V; ROWE, Christopher C; ACKERMAN, Uwe et al.Annals of neurology. 2010, Vol 68, Num 6, pp 959-962, issn 0364-5134, 4 p.Article

Brain glucose metabolism in Rett syndromeVILLEMAGNE, Patricia M; NAIDU, Sakkubai; VILLEMAGNE, Victor L et al.Pediatric neurology. 2002, Vol 27, Num 2, pp 117-122, issn 0887-8994Article

Serial [¹⁸F]fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. CommentaryMELTZER, Carolyn Cidis; KONDZIOLKA, Douglas; TAYLOR, Christopher L et al.Neurosurgery. 2001, Vol 49, Num 3, pp 586-592, issn 0148-396XArticle

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's diseaseYEN YING LIM; MARUFF, Paul; VILLEMAGNE, Victor L et al.Brain. 2014, Vol 137, pp 221-231, issn 0006-8950, 11 p., 1Article

Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's diseaseCHETELAT, Gaël; VILLEMAGNE, Victor L; AMES, David et al.Brain. 2011, Vol 134, pp 798-807, issn 0006-8950, 10 p., 3Article

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of agingROWE, Christopher C; ELLIS, Kathryn A; PRICE, Roger et al.Neurobiology of aging. 2010, Vol 31, Num 8, pp 1275-1283, issn 0197-4580, 9 p.Article

Β-amyloid imaging and memory in non-demented individuals : evidence for preclinical Alzheimer's diseasePIKE, Kerryn E; SAVAGE, Greg; VILLEMAGNE, Victor L et al.Brain. 2007, Vol 130, pp 2837-2844, issn 0006-8950, 8 p., 11Article

Intravenous nicotine reduces cerebral glucose metabolism: A preliminary studySTAPLETON, June M; GILSON, Stephen F; WONG, Dean F et al.Neuropsychopharmacology (New York, NY). 2003, Vol 28, Num 4, pp 765-772, issn 0893-133X, 8 p.Article

Sequential H₂¹⁵O PET studies in baboons: Before and after amphetaminePRICE, Julie C; DREVETS, Wayne C; RUSZKIEWICZ, James et al.The Journal of nuclear medicine (1978). 2002, Vol 43, Num 8, pp 1090-1100, issn 0161-5505, 11 p.Article

Gender-specific aging effects on the serotonin 1A receptorMELTZER, Carolyn Cidis; DREVETS, Wayne C; REYNOLDS, Charles F et al.Brain research. 2001, Vol 895, Num 1-2, pp 9-17, issn 0006-8993Article